All Infection Prevention & Control articles – Page 67
-
NewsIntranasal herpes infection may produce neurobehavioral symptoms, study finds
A new study finds that herpes infection through the nose can lead to anxiety, motor impairment and cognitive issues. The research is the first to show that, by exploiting a cellular enzyme, the virus can produce behavioral symptoms.
-
NewsStudy discovers tuberculosis genes necessary for airborne transmission
Tuberculosis bacteria rely on a family of genes that help them survive the challenging journey from one person’s lungs to another person’s during coughing, sneezing or talking, according to a study that offers new targets for tuberculosis therapies.
-
NewsPurified immunoglobulin F(ab′) 2 prevents lethal staphylococcal enterotoxin B intoxication in mice and rhesus monkeys
Purified F(ab′)2 fragments are an effective antidote to lethal SEB doses in mice and rhesus monkeys, and therefore might be a favorable candidate for treating patients with severe SEB intoxication, a new study suggests.
-
NewssiRNA-AGO2 complex inhibits bacterial gene translation: a novel therapeutic strategy for superbug infection
Scientists have demonstrated that exosomes can serve as delivery vehicles to introduce AGO2-loaded siRNA into the cytoplasm of bacteria, and in turn down-regulated gene expression of the mRNA that shares sequence complementarity to the siRNA.
-
NewsEradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25.
-
NewsNew study links sleep debt and night shifts to increased infection risk among nurses
A new study examining the effects of sleep patterns and shift work on the immune system has found that sleep debt and night shifts increase the risk of several common infections in nurses.
-
NewsBAADesign enables the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants
BAADesign offers a powerful tool for reengineering monoclonal antibodies to combat emerging SARS-CoV-2 variants, providing a scalable solution for future pandemic preparedness, according to a new study.
-
NewsCentauri Therapeutics selects first clinical candidate for immunotherapeutic treatment of Gram-negative bacterial infections
Centauri Therapeutics Limited has announced the selection of its first clinical candidate in the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial infections in the lung.
-
NewsStudy: Smartwatches could end the next pandemic
Everyday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — new research shows how they could help stop a pandemic before it even begins.
-
NewsMontana State scientist receives $2.8 million grant to advance Lyme disease research
Funding from the National Institutes of Health will allow a Montana State University research team to deepen explorations into a disease that is posing an increasing threat in the U.S. Lyme disease is a bacterial infection transmitted by ticks.
-
NewsStudy compares indoor transmission-risk metrics for infectious diseases
A recent study delves into the complex world of assessing the transmission risk of infectious diseases in indoor spaces. Understanding how to accurately evaluate the effectiveness of non-pharmaceutical interventions (NPIs) has become crucial.
-
NewsReactive nitrogen species dominance is key in the fight against antimicrobial resistance
The balance between two types of molecules – reactive nitrogen species (RNS) and reactive oxygen species (ROS) – plays a crucial role in tackling drug-resistant bacteria, according to a new study.
-
NewsFlu vaccine offers moderate protection against strains dominant in most European countries in 2024/2025
According to interim analysis of influenza vaccine effectiveness for the 2024/2025 season in Europe, the vaccine offered moderate protection against dominant influenza A strains, and strong protection against influenza B.
-
NewsNewly launched Enodia Therapeutics is a biotech company with a new approach for targeted protein degradation
Argobio and the Institut Pasteur have announced the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for treating cancer, inflammatory diseases and viral infections.
-
NewsA new test will make it possible to detect the parasite responsible for trichomoniasis more quickly and inexpensively
A sensitive, cheap and rapid test is developed to detect the parasite, Trichomonas vaginalis, which causes one of the world’s most common sexually transmitted infections, using an innovative approach that targets highly specific molecules with short nucleic acid sequences.
-
NewsThe International Space Station is overly sterile - so making it ‘dirtier’ could improve astronaut health
The International Space Station (ISS) has a much lower diversity of microbes compared to human-built environments on Earth, and the microbes that are present are mostly species carried by humans onto the ISS, suggesting that the presence of more microbes from nature could help improve human health in the space station.
-
NewsNew insights into how specific gut cells respond to bacterial toxins
Researchers have characterized a specific gut cell type, BEST4/CA7+ cells, with the ability to interact with immune cytokine interferon-γ (IFNγ), and its regulation in cellular electrolyte and water balance, in response to bacterial toxins.
-
NewsBacteria consumed by immune cells become part of the cell
Immune cells that eat bacteria in the body don’t stash them in specialized compartments as once thought, but turn them into critical nutrients that build proteins, create energy and keep the cells alive, according to a new study.
-
NewsSuperbugs in our food: a new hope for tackling drug resistance
Researchers highlight the potential of quorum sensing inhibitors (QSIs) as a novel approach to tackle Pseudomonas aeruginosa. The study explores the mechanisms of action of various QSIs and potential applications in food safety and healthcare.
-
NewsBeacon Technology Solutions, Illinois Tech awarded grant to advance far-UVC disinfection research
Beacon Technology Solutions, with collaborators at Illinois Institute of Technology, has been awarded a grant to support a novel study on how Far-UVC technology can help mitigate the spread of infectious diseases in public spaces.